Seborrheic dermatitis, a common skin condition, can lead to the formation of red, flaky patches on the scalp, face, or other parts of the body. While there isn’t a known permanent solution for ...

In the world of microbes, the evolution of resistance to antimicrobial drugs is a process that is nearly inevitable. (1) ...

Seborrheic dermatitis is an inflammatory skin condition that causes swelling, scales, and itchy rashes on the scalp, face, ...

It is often confused with acne vulgaris, rosacea, and seborrheic dermatitis. The condition's precise etiology remains unknown, though it is often triggered by topical corticosteroids. Oral and ...

ZORYVE foam represents the first topical treatment for seborrheic dermatitis with a new mechanism of action approved in Canada in over two decades1 Second approval of ZORYVE outside of the United ...

(RTTNews) - Arcutis Canada announced that Health Canada has approved ZORYVE for the treatment of seborrheic dermatitis in patients 9 years of age and older. The Health Canada approval is based on ...

Seborrheic dermatitis affects over 2 million Canadians, presenting with symptoms that can significantly impact quality of life, such as red, scaly skin on the face and scalp, and potentially ...

He took no medications. A KOH preparation of his chest was negative. A diagnosis of seborrheic dermatitis was made. He was prescribed desonide lotion 0.05% for his face and chest and selenium ...